Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction Chemotherapy in Resectable Oral Squamous Cell Carcinoma
NCT01542931Phase 3Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2008
- Primary completion
- Dec 2015
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel, Cisplatin micelle injection (HA132) and fluorouracil in oral squamous cell carcinoma (OSCC), sponsored by Shanghai Jiao Tong University School of Medicine. Started Jan 2008; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracil
03
Conditions
oral squamous cell carcinoma (OSCC)
Beyond the preview
Go deeper on NCT01542931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01542931.